oral glp-1 for weight loss Wegovy Pill Wins FDA Approval as First Treatment Obesity and Feel fuller Novel oral GLP-1 receptor agonist
Description
Updated December 13, 2022
Commercial Launch ( Late 2027Early 2028): Commercial availability is expected, depending on manufacturing and supply

Available from: www.amgen.com/newsroom/press-releases/2022/12/amgen-presents-new-amg-133-phase-1-clinical-data-at-wcirdc-2022
GLP-1 is a term most people know now, thanks to the rise of weight loss medications like Zepbound and Wegovy
Prescribers should refer to the full prescribing information for these agents when making prescribing decisions
